Discover the history, evolution, and importance of clinical trials, from James Lind's scurvy study to modern registry ...

Overcoming the illusion of knowledge in clinical research can enhance decision-making, training, and project success—helping ...

ClearNote Health announced initiation of patient enrollment for a landmark UK clinical study utilizing its Avantect ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) remained free ...

Israel’s Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT-90 160 patient phase 2b macrodose clinical trial:Tel Aviv University (TAU)’s Institute for Psychedelic Research locate ...

SNIPR Biome ApS ("SNIPR”), the company pioneering the development of precision medicines using CRISPR technology for microbial gene therapy, today announced that the first patient has been dosed in ...

SII and DNDi will develop a work plan to implement research and development, Phase 3 clinical trials, and access activities, ...

Navigating a complex drug development landscape, sponsors must rethink their approach to risk in study design and execution.

While cancelled NIH grants and regulatory uncertainty are less hospitable to clinical research in the U.S., Europe must play ...

Reported cumulative MMR rate of 47% (25 of 53) by 24 weeks with 32% (13 of 41) of patients achieving MMR by 24 weeks, which continues to compare favorably to precedent ...

Late-breaking data reveal durable improvements in joint, skin, and quality of life outcomes with deucravacitinib.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the MOBILIZE-1 ...